RhumbLine Advisers
CALA

RhumbLine Advisers’s Calithera Biosciences, Inc CALA Stock Holding History

RhumbLine Advisers’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,496
Closed -$169K – 3168
2021
Q1 		$169K Sell
3,496
-192
-5% -$11.2K ﹤0.01% 2868
2020
Q4 		$362K Buy
3,688
+276
+8% +$24.2K ﹤0.01% 2585
2020
Q3 		$235K Sell
3,412
-569
-14% -$49.6K ﹤0.01% 2624
2020
Q2 		$420K Buy
3,981
+141
+4% +$16.7K ﹤0.01% 2426
2020
Q1 		$341K Buy
3,840
+619
+19% +$73.7K ﹤0.01% 2342
2019
Q4 		$368K Buy
3,221
+300
+10% +$22.6K ﹤0.01% 2500
2019
Q3 		$180K Buy
2,921
+462
+19% +$37K ﹤0.01% 2770
2019
Q2 		$192K Buy
2,459
+99
+4% +$11.2K ﹤0.01% 2796
2019
Q1 		$318K Buy
2,360
+93
+4% +$9.77K ﹤0.01% 2517
2018
Q4 		$182K Buy
2,267
+681
+43% +$67.2K ﹤0.01% 2760
2018
Q3 		$167K Hold
1,586
– – ﹤0.01% 2782
2018
Q2 		$159K Buy
1,586
+191
+14% +$21.6K ﹤0.01% 2792
2018
Q1 		$176K Sell
1,395
-47
-3% -$7.33K ﹤0.01% 2639
2017
Q4 		$241K Sell
1,442
-287
-17% -$73.5K ﹤0.01% 2553
2017
Q3 		$545K Buy
1,729
+37
+2% +$11.7K ﹤0.01% 2270
2017
Q2 		$503K Buy
+1,692
New +$453K ﹤0.01% 2304
2016
Q2 		– Sell
-805
Closed -$91K – 3041
2016
Q1 		$91K Buy
805
+77
+11% +$8.72K ﹤0.01% 2911
2015
Q4 		$111K Buy
728
+34
+5% +$5.1K ﹤0.01% 2938
2015
Q3 		$75K Buy
694
+37
+6% +$4.79K ﹤0.01% 2971
2015
Q2 		$94K Buy
+657
New +$152K ﹤0.01% 3012

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers's CALA Position: Q2 2021 in Review

RhumbLine Advisers sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 3,496 shares — an estimated $169K sold.

RhumbLine Advisers first reported a position in CALA in Q2 2015 and held it in 20 quarters. The position peaked at $545K in Q3 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • RhumbLine Advisers reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • RhumbLine Advisers sold 3,496 Calithera Biosciences, Inc shares in Q2 2021, an estimated $169K.
  • RhumbLine Advisers first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 20 quarters.
  • RhumbLine Advisers's Calithera Biosciences, Inc position peaked at $545K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.